HA
TEVA icon

Heartland Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Heartland Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,775
Closed -$256K – 202
2016
Q1 		$256K Sell
4,775
-195,640
-98% -$11.5M 0.01% 179
2015
Q4 		$13.2M Sell
200,415
-52,745
-21% -$3.26M 0.53% 64
2015
Q3 		$14.4M Sell
253,160
-5,527
-2% -$358K 0.53% 63
2015
Q2 		$15.3M Sell
258,687
-77,571
-23% -$4.79M 0.43% 84
2015
Q1 		$20.9M Sell
336,258
-149,168
-31% -$8.67M 0.52% 67
2014
Q4 		$27.9M Sell
485,426
-14,089
-3% -$785K 0.55% 66
2014
Q3 		$26.8M Sell
499,515
-13,823
-3% -$732K 0.52% 71
2014
Q2 		$26.9M Sell
513,338
-118,383
-19% -$6.05M 0.47% 81
2014
Q1 		$33.4M Sell
631,721
-9,856
-2% -$456K 0.59% 52
2013
Q4 		$25.7M Buy
641,577
+5,926
+0.9% +$233K 0.45% 83
2013
Q3 		$24M Buy
635,651
+548,966
+633% +$21.4M 0.44% 86
2013
Q2 		$3.35M Buy
+86,685
New +$3.38M 0.06% 211

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Heartland Advisors's TEVA Position: Q2 2016 in Review

Heartland Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 4,775 shares — an estimated $256K sold.

Heartland Advisors first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $33.4M in Q1 2014. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Heartland Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Heartland Advisors sold 4,775 Teva Pharmaceuticals shares in Q2 2016, an estimated $256K.
  • Heartland Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Heartland Advisors's Teva Pharmaceuticals position peaked at $33.4M in Q1 2014.
  • 812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Heartland Advisors's 13F filing for Q2 2016, filed 4 Aug 2016.